Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ie-Ming Shih

Showing results (311-320 of 352) with videos related to

Pageof 36
Sort By:
Cell Reports|December 9, 2020
Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives MetastasisHuihui Fan, Huda I Atiya, Yeh Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2019
Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor TherapyYoungran Park, M Herman Chui, Yohan Suryo Rahmanto, et al.
Cancer Research|December 18, 2025
Integrated Spatial Analysis Reveals the Molecular Landscape of Ovarian Precancerous LesionsTu-Yung Chang, Yen-Wei Chien, Szu-Hua Chen, et al.
Nature Communications|February 15, 2019
Genomic characterization of genes encoding histone acetylation modulator proteins identifies therapeutic targets for cancer treatmentZhongyi Hu, Junzhi Zhou, Junjie Jiang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 26, 2016
Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the EvidenceMark E Sherman, Ronny I Drapkin, Neil S Horowitz, et al.
The American Journal of Surgical Pathology|February 1, 2024
Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor LesionsYen-Wei Chien, Yeh Wang, Peng Huang, et al.
Nature Communications|June 3, 2020
Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogrammingYohan Suryo Rahmanto, Wenjing Shen, Xu Shi, et al.
The Journal of Pathology|March 19, 2019
TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic targetLin-Yu Chen, Rui-Lan Huang, Michael Wy Chan, et al.
American Journal of Clinical Pathology|January 29, 2013
A broad survey of cathepsin K immunoreactivity in human neoplasmsGang Zheng, Guido Martignoni, Cristina Antonescu, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Precision-engineered biomimetics: the human fallopian tubeAshleigh J Crawford, André Forjaz, Isha Bhorkar, et al.
Pageof 36

Showing results (311-320 of 352) with videos related to

Sort By:
Pageof 36
Cell Reports|December 9, 2020
Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives MetastasisHuihui Fan, Huda I Atiya, Yeh Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2019
Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor TherapyYoungran Park, M Herman Chui, Yohan Suryo Rahmanto, et al.
Cancer Research|December 18, 2025
Integrated Spatial Analysis Reveals the Molecular Landscape of Ovarian Precancerous LesionsTu-Yung Chang, Yen-Wei Chien, Szu-Hua Chen, et al.
Nature Communications|February 15, 2019
Genomic characterization of genes encoding histone acetylation modulator proteins identifies therapeutic targets for cancer treatmentZhongyi Hu, Junzhi Zhou, Junjie Jiang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 26, 2016
Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the EvidenceMark E Sherman, Ronny I Drapkin, Neil S Horowitz, et al.
The American Journal of Surgical Pathology|February 1, 2024
Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor LesionsYen-Wei Chien, Yeh Wang, Peng Huang, et al.
Nature Communications|June 3, 2020
Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogrammingYohan Suryo Rahmanto, Wenjing Shen, Xu Shi, et al.
The Journal of Pathology|March 19, 2019
TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic targetLin-Yu Chen, Rui-Lan Huang, Michael Wy Chan, et al.
American Journal of Clinical Pathology|January 29, 2013
A broad survey of cathepsin K immunoreactivity in human neoplasmsGang Zheng, Guido Martignoni, Cristina Antonescu, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Precision-engineered biomimetics: the human fallopian tubeAshleigh J Crawford, André Forjaz, Isha Bhorkar, et al.
Pageof 36